Table 1 Cross-sectional analysis of estimated GH compliance (frequency of missed injections) in 75 children
Frequency of missed injections
NilUp to 1/week>1–2/week>2/week
% Of total36% (27)25% (19)16% (12)23% (17)
group (n)
Age (years)12.311.911.914.2
Duration of GH1.**
therapy (years)†
Given choice of81%68%58%23%**
GH device
Prescription duration10%6%27%50%**
<4 weeks
Height velocity7.*
Height velocity0.470.470.420.05*
  • *p<0.05, **p<0.005 for linear trends.

  • †Similar results are seen after adjustment for age (not shown).

  • ‡Adjusted for age and duration of GH therapy.

  • Data are % of all subjects (n) or medians.